News on Cholesterol

2 articles have been published recently in the JAMA adding a little more confusion regarding dietary cholesterol and its association with Cardiovascular disease and mortality. The recent publication of the dietary guidelines for Americans proclaimed that it would no longer include the recommendation to limit dietary cholesterol to <300mg/day, as there was no appreciable relationship between dietary cholesterol and serum cholesterol. Although the guidelines advise to eat as little dietary cholesterol as possible, it sent the opposite message to the public. Recent study pooled individual level data from 29615 participants in 6 prospective cardiovascular disease studies in the US. The authors observed the following:

– The risk of dietary cholesterol affecting cardiovascular outcomes is probably modest only. However, consumption of every additional 300mg of dietary cholesterol was associated with a higher risk of incident cardiovascular disease and total mortality.

– The increased risk ranged from 1 to 4% over a 17.5-year follow-up period.

– The studies done so far also suggest dietary cholesterol could have variable effects on different cardiovascular diseases i.e. strokes, heart attacks and heart failure.

– The risk of adverse events was not seen in those who had a very low cholesterol at base line i.e. those with elevated base line cholesterols (LDL) had a higher risk for adverse cardiovascular events.

– The authors assert that high sodium foods and foods rich in simple carbohydrates (sugars, sweets and polished cereals) and trans fats should be avoided altogether. They also advised that the individual checks his cholesterol levels and adjusts his diet accordingly.

In another study published this month in the JAMA, TMAO (Trimethylamine N-oxide) was identified as a possible culprit in producing cardiovascular disease and increasing all cause mortality. In the previous decades, doctors had pinned the blame for heart disease on saturated fats. The long chain saturated fatty acids in meat steaks, butter and coconut oil which raised the LDL cholesterol was thought to be the culprit for heart disease and death. Recent meta-analysis of dietary recall studies seems to suggest that this relationship was not as tight as previously thought. Researchers are currently homing in on another possible culprit i.e. TMAO which is possibly an additional biological pathway by which red meat increased heart disease risk. The body makes TMAO from foods with choline and L-carnitine which are found abundantly in meat, poultry, fish, dairy and egg yolks. These proteins are broken down by gut bacteria to form trimethylamine (TMA) which is then converted into TMAO in the liver. Red meat is high in L-carnitine and has been shown to raise the TMAO levels more than white meat or non-meat proteins. It also tends to shift the gut microbiome, fuelling more bacteria to produce TMA. The authors conclude that the carnitine-TMAO pathway is a partial reason for the heighted mortality and cardiovascular risk with chronic red meat diet. They conclude that TMAO generation requires the right gut bacteria and this could be another path to reducing cardiovascular events.

Author’s note:

– This may be another reason to take pro-biotic rich foods although we are still unsure as to which bacteria are truly beneficial.

– There are so many different processes that affect what happens inside the body. It is therefore important not to get carried away with every new theory and finding but to adopt moderation in dietary habits and to focus on having adequate plant-based, whole-grain, fibre-enriched and balanced diet.

Are we ready for Personalised medical treatment?

Physicians have always treated disease after their onset. But the sheer increasing number of disease and the escalating costs of treatment has made many think about ways to prevent disease before they occur. Disease prevention is thought of as Primary Prevention when preventive steps are taken before the first episode of the illness itself. It would require the treatment of risk factors that if left uncorrected would lead on to disease. For e.g., treatment of Hypertension, Diabetes and Dyslipidaemia before the onset of Cardiovascular diseases such as Heart Attacks and Strokes. Secondary Prevention are steps and treatments that are given to prevent the second episode of a disease. This would be the medical treatment of Cardiovascular disease with anti platelet drugs such as Aspirin, Statins etc. Primordial prevention refers to correction of lifestyle abnormalities at a very young age much before the onset of even the risk factors for the disease. These would include regular exercise, maintenance of ideal body weight, adequate sleep, intake of a well balanced diet and dietary supplementation.

 

Although most doctors have focussed their efforts on treating already established disease, it is becoming increasingly clearer that adopting preventing strategies may be the need of the hour. While recommendation exist from world bodies such as the WHO, the questions many physicians are asking is if medical therapy can be individualised and personalised. Is there a way to identify the risk for disease even before disease onset? Would genetic test be of any help in identifying risks of Non Communicable diseases (NCD – heart and vascular disease, Kidney failure, Cancer etc)? Can they be used to guide personalised recommendations for disease prevention?

 

Genetic tests have been used to predict risks for Breast and Colonic cancer and those with high risk are also advised an option of surgery to reduce that risk. Pharmacogenomics and Neutrigenomics are terms that are used to describe the prescription of pharmaceutical agents and nutritional supplements to reduce the risks of cancer/disease. This field, although in its infancy provides hope of big achievements in personalised Primordial preventive strategies.

 

A recent article in an International Medical journal  discussed the effectiveness of genetic testing to suggest disease susceptibility and to suggest preventive measures in an attempt at primary prevention of diseases.Their findings suggested that genetic testing had a 25% sensitivity only of predicting future events and that current evidence isn’t enough to suggest widespread screening using these tests. The low sensitivity (accuracy) of these tests could be explained by the observations that the genes that confer risk are multiple, the interaction with each other and with lifestyle factors complex and our understanding of them rudimentary at present!

 

Although very attractive, the concept of Personalised Preventive Medicine is a long way off and for now would only interest researchers or those who are simply curious to know what their genes may be saying. Even if the sensitivity of genetic testing is low, it might give the curious an insight into their disease susceptibility risks and suggest ways to modify their lifestyles to prevent disease in the future.

 

Genetic testing isn’t very expensive and can be done at Chennai for Rs. 20000/- The tests include identification of genes predicting Non communicable diseases, genes for drug allergies and for prediction of drug interactions.